Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Nature. 2022 Nov 30;613(7945):767–774. doi: 10.1038/s41586-022-05588-y

Extended Data Table 1 |.

Summary of binding affinities, cAMP and arrestin recruitment values of fentanyl amino and guano bitopics on μOR

Binding a cAMPb β-arrestin2b

Ligands Ki ± SEM (nM) EC50 (nM) pEC50 ± SEM Emax ± SEM (%) EC50 (nM) pEC50 ± SEM Emax ± SEM (%)
C3 amino > 1000 12300 4.9 ± 0.2 142 ± 20 n.d. n.d. 8.2 ± 1.1
C3 guano 77 ± 3.0 164 6.8 ± 0.1 107 ± 2.3 n.d. n.d. 6.9 ± 2.4
C5 amino 1179 ± 13 469 6.3 ± 0.2 90 ± 5.9 n.d. n.d. n.d.
C5 guano 4.6 ± 0.7 0.8 9.1 ± 0.1 104 ± 3.1 4710 5.3 ± 0.1 54 ± 3.2
C6 amino 1033 ± 15 844 6.1 ± 0.1 126 ± 4.7 n.d. n.d. 20 ± 2.3
C6 guano 4.1 ± 0.3 4.7 8.3 ± 0.1 137 ± 2.1 n.d. n.d. 19 ± 1.4
C7 amino 369 ± 7.0 436 6.4 ± 0.1 109 ± 3.9 n.d. n.d. n.d.
C7 guano 41 ± 8.0 62 7.2 ± 0.1 109 ± 2.4 n.d. n.d. 13 ± 1.4
C9 amino 281 ± 2.2 360 6.4 ± 0.1 106 ± 4.6 66720 4.2 ± 0.2 56 ± 9.4
C9 guano 58 ± 8.0 21.3 7.7 ± 0.1 128 ± 3.2 792 5.1 ± 0.1 120 ± 6.6
C11amino 589 ± 13 293.2 6.5 ± 0.1 105 ± 3.6 n.d. n.d. n.d
C11 guano 165 ± 4 1020 6.0 ± 0.1 118 ± 5.2 n.d. n.d. n.d.
Fentanyl 9.1 ± 3.1 0.90 9.0 ± 0.1 86 ± 1.8 66.2 7.2 ± 0.1 119 ± 2.7
DAMGO n.d. 0.40 9.4 ± 0.1 99 ± 4 723 6.1 ± 0.1 100 ± 2.8
a

Ki binding competition studies were performed with the indicated compound against 125I-IBNtxA (0.1 nM) in membranes from CHO cells stably expressing the μOR cloned mouse opioid receptor. Results are presented as Ki ± SEM (nM) from three independent experiments performed in triplicate.

b

Potency and efficacy data were obtained using agonist induced inhibition measured by cyclic AMP (cAMP) and Tango assay for β-arrestin 2 recruitment, respectively, from three independent experiments performed in triplicate. Efficacy is represented as EC50 (nM) and percent maximal stimulation (Emax) relative to standard agonist DAMGO. “n.d.” Denotes not determined. Efficacy<20%.